RT Journal Article
SR Electronic
T1 Acute kidney injury in patients hospitalized with COVID-19 in Wuhan, China: A single-center retrospective observational study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.06.20055194
DO 10.1101/2020.04.06.20055194
A1 Xiao, Guanhua
A1 Hu, Hongbin
A1 Wu, Feng
A1 Sha, Tong
A1 Huang, Qiaobing
A1 Li, Haijun
A1 Han, Jiafa
A1 Song, Wenhong
A1 Chen, Zhongqing
A1 Zeng, Zhenhua
YR 2020
UL http://medrxiv.org/content/early/2020/04/08/2020.04.06.20055194.abstract
AB Background The kidney may be affected in coronavirus-2019 disease (COVID-19). This study assessed the predictors and outcomes of acute kidney injury (AKI) among individuals with COVID-19.Methods This observational study, included data on all patients with clinically confirmed COVID-19 admitted to Hankou Hospital, Wuhan, China from January 5 to March 8, 2020. Data were extracted from clinical and laboratory records. Follow-up was censored on March 8, 2020.This is a single-center, retrospective, observational study. Patients clinically confirmed COVID-19 and admitted to Hankou Hospital, Wuhan, China from January 5 to March 8, 2020 were enrolled. We evaluated the association between changes in the incidence of AKI and COVID-19 disease and clinical outcomes by using logistic regression models.Results A total of 287 patients, 55 with AKI and 232 without AKI, were included in the analysis. Compared to patients without AKI, AKI patients were older, predominantly male, and were more likely to present with hypoxia and have pre-existing hypertension and cerebrovascular disease. Moreover, AKI patients had higher levels of white blood cells, D-dimer, aspartate aminotransferase, total bilirubin, creatine kinase, lactate dehydrogenase, procalcitonin, C-reactive protein, a higher prevalence of hyperkalemia, lower lymphocyte counts, and higher chest computed tomographic scores. The incidence of stage 1 AKI was 14.3%, and the incidence of stage 2 or 3 AKI was 4.9%. Patients with AKI had substantially higher mortality.Conclusions AKI is an important complication of COVID-19. Older age, male, multiple pre-existing comorbidities, lymphopenia, increased infection indicators, elevated D-dimer, and impaired heart and liver functions were the risk factors of AKI. AKI patients who progressed to stages 2 or 3 AKI had a higher mortality rate. Prevention of AKI and monitoring of kidney function is very important for COVID-19 patients.Trial registration NCT04316299(03/19/2020)Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04316299Funding StatementThis work was supported by the Natural Science Foundation of China Grant 81871604; the Natural Science Foundation of Guangdong Province, China, Grants 2016A030310389 and 2017A030313590; the Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University, Guangzhou, China, Grant 2016J011.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData sharing is not applicable to this article as no datasets were generated or analysed during the current study.AKIAcute kidney injuryCOVID-19Coronavirus disease 2019eGFREstimated glomerular filtration rateMDRDModification of Diet in Renal DiseaseCTComputed tomographyPCRPolymerase chain reactionACE2Angiotensin converting enzyme IISARS-CoVServe acute respiratory syndrome coronavirusWHOWorld Healthy Organization